New England Peptide, LLC (NEP), has named Robert P. Hammer, Ph.D., director of chemical development. Gardner, Mass. (PRWEB) September 30, 2008 — New England Peptide, LLC (NEP), has named Robert P. Hammer, Ph.D., director of chemical development. Hammer comes to NEP from Louisiana State University (LSU), where he was the William A. Pryor professor of […]
Pantheon Helps Research Scientists Save Time and Make Better Decisions, and is Easily Extensible by Corporate Discovery Organizations and Other Discovery Providers ST. LOUIS–Tripos International, a leading provider of drug discovery informatics products and services, today announced the development of PantheonTM, a new, flexible and powerful software platform created to address the CADD and cheminformatics […]
Leaders in sequence informatics and desktop sequence analysis join forces to provide users with enhanced, interoperable sequence search, analysis and data management capabilities WESTBOROUGH, Mass.–GenomeQuest and Invitrogen today announced that the GenomeQuest™ 5.0 web-based sequence search, analysis and data management platform is now interoperable with Invitrogen’s Vector NTI Advance™ desktop sequence analysis solution. Ronald Ranauro, […]
SAN DIEGO, Oct. 1 — SoluLinK, Inc., a leader in conjugation products and complete easy to use kits, announces the introduction of its newest product, the One-Shot ChromaLink Antibody Labeling Kit. This innovative kit includes all the components for the rapid traceable biotinylation of a single antibody. The kit features SoluLinK’s patented sulfo-ChromaLink Biotin linker, […]
VEDBAEK, Denmark, October 1 — – Announcement No. 40/2008 – To OMX Nordic Exchange Copenhagen and the Press. Exiqon A/S today announces a grant of license to Roche Diagnostics for use of the Universal ProbeLibrary that is based on Exiqon’s proprietary LNA(TM) detection technology. Roche Diagnostics will develop its new product line for RealTime ready […]
Affymetrix Inc. (Nasdaq:AFFX) and Medical Prognosis Institute A/S (MPI), a leading cancer diagnostic development company based in Denmark, today announced that they have signed a Powered by Affymetrix(TM) (PbA) agreement. With this agreement, MPI gains non-exclusive access to Affymetrix microarray technology to develop and commercialize drug sensitivity prediction and prognostic products for patients with cancer. […]
SAN DIEGO, Oct. 1 — SoluLinK, Inc., a leader in conjugation products and complete easy to use kits, announces the introduction of its newest product, the One-Shot ChromaLink Antibody Labeling Kit. This innovative kit includes all the components for the rapid traceable biotinylation of a single antibody. The kit features SoluLinK’s patented sulfo-ChromaLink Biotin linker, […]
ST. JOSEPH, Mich., Sept. 30 — GeneGo Inc., a leading provider of databases, tools and services in systems biology, announced today that they were awarded with a Phase I SBIR grant from the National Cancer Institute (NCI) for the development of a platform for understanding the influence of nutrients on cancerogenesis and cancer prevention. GeneGo […]
454 Life Sciences, a Roche company, and GenomeQuest, Inc. announced a co-marketing agreement whereby GenomeQuest will offer its recently launched On-Demand Informatics Service to users of the 454 Genome Sequencer FLX System. GenomeQuest’s high-throughput annotation and data management tools enable rapid characterization of all sequences generated by the Genome Sequencer FLX System. The combination of […]
Cellumen, Inc. today announced an agreement with the Alzheimer’s Drug Discovery Foundation (ADDF) to apply Cellumen’s Cellular Systems Biology (CSB) technology to create a cellular model of Alzheimer’s disease. The main objective of the partnership is for Cellumen to develop a panel of CSB assays, as well as biosensors of key protein:protein interactions, that reveal […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
